Abstract
Acute administration of lorazepam (0.25 and 0.5 mg/kg) and triazolam (0.075–0.25 mg/kg) significantly reduced the locomotor activity of rats placed in a holeboard for 10 min. Acute injections of lorazepam (0.25 and 0.5 mg/kg) and triazolam (0.05–0.25 mg/kg) also significantly reduced exploration, measured by the number of head-dips and the time spent head-dipping. After 3 days of pretreatment, tolerance developed to the sedative effects of these drugs: lorazepam (0.25 mg/kg) and triazolam (0.05 and 1 mg/kg) were without significant effect, and lorazepam (0.5 mg/kg) had only the effect of half that dose given acutely. Some of this behavioural tolerance could be attributed to changes in drug metabolism, and the development of tolerance did not require continuous presence of drug in brain and plasma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Archer J (1973) Tests for emotionality in rats and mice: a review. Anim Behav 21:205–235
Christensen JD (1973) Tolerance development with chlordiazepoxide in relation to the plasma levels of the parent compound and its main metabolites in mice. Acta Pharmacol Toxicol 33:267–272
Cook L, Sepinwall J (1975) Behavioural analysis of the effects and mechanisms of action of benzodiazepines. (Costa E, Greengard P, eds) Raven Press, New York, p 1
Eberts EF (1974) Comparative metabolism of triazolam, a new sedative-hypnotic, in rat, dog and man. Pharmacologist 16:196
File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19–24
File SE, Wardill AG (1975a) The reliability of the holeboard apparatus. Psychopharmacologia 44:47–51
File SE, Wardill AG (1975b) Validity of head-dipping as a measure of exploration in a modified holeboard. Psychopharmacologia 44:53–59
Goldberg ME, Manian AA, Efron DH (1967) A comparative study of certain pharmacologic responses following acute and chronic administrations of chlordiazepoxide. Life Sci 6:481–491
Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice. Raven Press, New York
Hoogland DR, Miya TS, Bousquet WF (1966) Metabolism and tolerance studies with CDP-214-C in the rat. Tox Appl Pharmacol 9:116–123
Hughes RN (1972) Chlordiazepoxide modified exploration in rats. Psychopharmacologia 24:462–469
Jori A, Prestini PE, Pugliatti C (1969) Effect of diazepam and chlordiazepoxide on the metabolism of other drugs. J Pharm Pharmacol 21:387–390
Lader MH, Curry S, Baker WJ (1980) Physiological and psychological effects of chlorazepate in man. Br J Clin Pharmacol 9:83–90
Margules DL, Stein L (1968) Increase of “antianxiety” activity and tolerance of behavioural depression during chronic administration of oxazepam. Psychopharmacologia 13:74–80
Onhaus EE, Park BK, Colombo JP, Heizmann P (1979) The effect of enzyme induction on diazepam metabolism in man. Brit J Clin Pharmacol 8:557–563
Orme M, Breckenridge A, Brooks RV (1972) Interactions of benzodiazepines with warfarin. Br Med J 3:611–614
Sheldon MH (1968) Exploratory behaviour: the inadequacy of activity measures. Psychon Sci 11:38
Stein L, Berger BD (1971) Psychopharmacology of 7-chloro 5-(O-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (Lorazepam) in squirrel, monkey and rat. Arzneim Forsch 21:1073–1078
Wise D, Berger BD, Stein L (1972) Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177:180–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
File, S.E. Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology 73, 240–245 (1981). https://doi.org/10.1007/BF00422410
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00422410